A first-in-human study of the novel metabolism-based anti-cancer agent SM-88 in subjects with advanced metastatic cancer

Conclusions The results of this study support continued development of SM-88.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research